Effectiveness of Nasolacrimal SCC Treatments and Promising Role of Chemo-Induction: A Case Report and Systematic Review.
HPV status
eye exenteration
histopathology
induction
metastasis
nasolacrimal squamous cell carcinoma
overall survival
recurrence
treatments
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
revised:
29
02
2024
received:
28
10
2023
accepted:
19
03
2024
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
23
4
2024
Statut:
aheadofprint
Résumé
To comprehensively analyze reported cases of nasolacrimal squamous cell carcinoma (NLSCC), focusing on risk factors, treatment modalities, and outcomes. Additionally, investigate the impact of human Papillomavirus (HPV) status and histopathological subtypes' impact on prognosis. Pubmed, Embase. We conducted a systematic literature review to identify relevant studies reporting cases of NLSCC. The review methods adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The final update was performed on May 31, 2023. The 72 studies included a total of 313 participants (mean age: 55; 60% male). Longer symptom duration (44.1 ± 59.2 months) correlated with recurrence (p = 0.004), and males exhibited higher mortality rates (19.6% vs. 2.4% in females, p = 0.01). The overall survival (OS) rate among all patients was 87.1%. Basaloid NLSCC had a worse death outcome (p ≤ 0.001). HPV-positive cases showed comparable OS, recurrence, and metastasis rates to the general population (p = 0.917, 0.851, 0.07, respectively). Comparing treatment approaches (surgery, surgery with adjuvant radiation, chemoradiotherapy [CRT] followed by surgery), no significant differences in 5 and 10-year OS rates or recurrence were observed (p = 0.4, 0.24, respectively), but 5-year metastasis events were significant (p = 0.024). Eye exenteration rates were 31.1%, 20%, and 0% for the respective treatments (p = 0.089). Induction chemotherapy saved four cases from potential exenteration with favorable prognosis. Early detection and diagnosis are of utmost importance in the management of NLSCC. Regardless of the treatment approach, HPV-related NLSCC demonstrated similar outcomes to the general population. Basaloid histology represents the worst subtype in terms of prognosis. Limited adjuvant CRT cases showed improved outcomes and induction chemotherapy's importance was emphasized in recent literature and our shared experience. Laryngoscope, 2024.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.
Références
Kuo C‐Y, Tsai C‐C, Kao S‐C, Hsu W‐M, Jui‐Ling LC. Comparison of clinical features and treatment outcome in benign and malignant lacrimal sac tumors. Biomed Res Int. 2020;2020:1‐4. https://doi.org/10.1155/2020/3545839.
Ramberg I, Toft PB, Heegaard S. Carcinomas of the lacrimal drainage system. Surv Ophthalmol. 2020;65(6):691‐707. https://doi.org/10.1016/j.survophthal.2020.04.001.
Montalban A, Liétin B, Louvrier C, et al. Malignant lacrimal sac tumors. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127(5):165‐172. https://doi.org/10.1016/j.anorl.2010.09.001.
Afrogheh AH, Jakobiec FA, Hammon R, et al. Evaluation for high‐risk HPV in squamous cell carcinomas and precursor lesions arising in the conjunctiva and lacrimal sac. Am J Surg Pathol. 2016;40(4):519‐528. https://doi.org/10.1097/PAS.0000000000000581.
Mokhtari TE, Warinner C, Edwards H, et al. Unusual presentation of HPV‐positive squamous cell carcinoma of the nasolacrimal duct as carcinoma of unknown primary. Am J Otolaryngol. 2022;43(3):103457. https://doi.org/10.1016/j.amjoto.2022.103457.
Page MJ, McKenzie JE, Bossuyt PM, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103‐112. https://doi.org/10.1016/j.jclinepi.2021.02.003.
Zhao J, Quon H, Koch W, Rooper LM, Campbell AA. High‐risk human papillomavirus positive primary squamous cell carcinoma of the lacrimal gland: a case report. Orbit. 2021;40(1):65‐68. https://doi.org/10.1080/01676830.2020.1718714.
Hongo T, Yamamoto H, Tanabe M, et al. High‐risk HPV‐related squamous cell carcinoma in the conjunctiva and lacrimal sac. Am J Surg Pathol. 2022;46(7):977‐987. https://doi.org/10.1097/PAS.0000000000001857.
Madreperla SA, Green WR, Daniel R, Shah KV. Human papillomavirus in primary epithelial tumors of the Lacrunal sac. Ophthalmology. 1993;100(4):569‐573. https://doi.org/10.1016/S0161-6420(93)31629-5.
Ramberg I, Vieira FG, Toft PB, von Buchwald C, Heegaard S. Viral and genomic drivers of squamous cell neoplasms arising in the lacrimal drainage system. Cancers (Basel). 2022;14(10):2558. https://doi.org/10.3390/cancers14102558.
Charles NC. Carcinoma of the lacrimal canaliculus masquerading as Canaliculitis. Arch Ophthalmol. 2006;124(3):414‐416. https://doi.org/10.1001/archopht.124.3.414.
Ang T, Juniat V, Selva D. Letter to the editor: bilateral lacrimal sac squamous cell carcinoma. Orbit. 2021;40(4):352‐353. https://doi.org/10.1080/01676830.2021.1893344.
Ogawa T, Yo K, Okamoto H, et al. A novel treatment strategy for advanced lacrimal sac carcinomas confirmed by p16 immunostaining. Semin Ophthalmol. 2022;37(3):307‐312. https://doi.org/10.1080/08820538.2021.1963458.
Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction. Br J Ophthalmol. 1997;81(4):308‐313. https://doi.org/10.1136/bjo.81.4.308.
Suárez C, Ferlito A, Lund VJ, et al. Management of the orbit in malignant sinonasal tumors. Head Neck. 2008;30(2):242‐250. https://doi.org/10.1002/hed.20736.
Song X, Wang J, Wang S, Wang W, Wang S, Zhu W. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol. 2018;256:1333‐1338. https://doi.org/10.1007/s00417-018-3962-4.
Yip CC, Eong KGA, Choo CT. Lacrimal sac tumour presenting with blood‐stained ocular discharge. Singapore Med J. 2002;43(3):156‐158.
Valenzuela AA, McNab AA, Selva D, O'Donnell BA, Whitehead KJ, Sullivan TJ. Clinical features and management of tumors affecting the lacrimal drainage apparatus. Ophthalmic Plast Reconstr Surg. 2006;22(2):96‐101. https://doi.org/10.1097/01.iop.0000198457.71173.7b.
Shi J, Tu Y, Wu W. Combined external, endoscopic, endonasal‐assisted En bloc resection of malignant tumors from the lacrimal drainage system. J Craniofac Surg. 2018;29(7):1855‐1858. https://doi.org/10.1097/SCS.0000000000004655.
Salib RJ, Afoakwah EO. De novo papillary squamous carcinoma of the lacrimal sac. Auris Nasus Larynx. 2003;30(2):205‐208. https://doi.org/10.1016/S0385-8146(03)00004-X.
Ryan SJ, Font RL. Primary epithelial neoplasms of the lacrimal sac. Am J Ophthalmol. 1973;76(1):73‐88. https://doi.org/10.1016/0002-9394(73)90014-7.
Milder B, Smith ME. Carcinoma of lacrimal sac. Am J Ophthalmol. 1968;65(5):782‐784. https://doi.org/10.1016/0002-9394(68)94399-7.
Hornblass A, Jakobiec FA, Bosniak S, Flanagan J. The diagnosis and management of epithelial tumors of the lacrimal sac. Ophthalmology. 1980;87(6):476‐490. https://doi.org/10.1016/S0161-6420(80)35205-6.
Siriwanasan R, Puranajoti S, Ittipunkul N, Martin T. Squamous cell carcinoma of the lacrimal sac: a case report. J Med Assoc Thailand Chotmaihet Thangphaet. 2004;87(1):106‐110.
Kohn R, Nofsinger K, Freedman SI. Rapid recurrence of papillary squamous cell carcinoma of the canaliculus. Am J Ophthalmol. 1981;92(3):363‐367. https://doi.org/10.1016/0002-9394(81)90525-0.
Alabiad CR, Weed DT, Walker TJ, et al. En bloc resection of lacrimal sac tumors and simultaneous orbital reconstruction. Ophthalmic Plast Reconstr Surg. 2014;30(6):459‐467. https://doi.org/10.1097/IOP.0000000000000134.
Hodgson N, Whipple K, Lin JH, Brumund KT, Kikkawa DO, Korn BS. Bilateral squamous cell carcinoma of the lacrimal sac. Ophthalmic Plast Reconstr Surg. 2013;29(6):e149‐e151. https://doi.org/10.1097/IOP.0b013e3182831c2d.
Song X, He H, Zhu Y, et al. Treatment outcomes after definitive radio(chemo)therapy for 17 lacrimal sac squamous cell carcinoma. Br J Radiol. 2020;93(1115):20190633. https://doi.org/10.1259/bjr.20190633.
Zhang R, Qian J, Meng F, et al. A staged procedure in the treatment of primary lacrimal sac epithelial malignancy: a retrospective cases analysis. Ophthalmic Plast Reconstr Surg. 2019;35(2):187‐192. https://doi.org/10.1097/IOP.0000000000001206.
Kanyinda N, Soni S, Ramadan A, Kidwell E. Complete resolution of a large squamous cell carcinoma of the lacrimal duct in a young African American male after non‐surgical management. Am J Ophthalmol Case Rep. 2020;19:100842. https://doi.org/10.1016/j.ajoc.2020.100842.
Wang P, Ma N, Zhang S, et al. Iodine‐125 interstitial brachytherapy for malignant lacrimal sac tumours: an innovative technique. Eye. 2021;35(4):1240‐1247. https://doi.org/10.1038/s41433-020-1098-3.
Islam S, Eisenberg RL, Hoffman GR. Malignant transformation of metachronous bilateral Schneiderian inverted papilloma of the lacrimal sac: management considerations and the contentious issue of orbital exenteration. Eur Arch Otorhinolaryngol. 2014;271(7):1857‐1860. https://doi.org/10.1007/s00405-013-2632-8.
El‐Sawy T, Frank SJ, Hanna E, et al. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthalmic Plast Reconstr Surg. 2013;29(6):454‐457. https://doi.org/10.1097/IOP.0b013e31829f3a73.
Ni C, D'amico DJ, Fan CHIQ, Kuo PK. Tumors of the lacrimal sac: a clinicopathological analysis of 82 cases. Int Ophthalmol Clin. 1982;22(1):121‐140.
Ramos A, Del PC, Chinchurreta A, García F, Lorenzo M, Gismero S. Adenoid cystic carcinoma of the lacrimal sac: case report. Arq Bras Oftalmol. 2016;79(5):333‐335. https://doi.org/10.5935/0004-2749.20160095.
Song X, Wang S, Wang J, et al. Clinical management and outcomes of lacrimal sac squamous cell carcinoma. Head Neck. 2019;41(4):974‐981. https://doi.org/10.1002/hed.25529.
Sagerman RH, Fariss AK, Chung CT, King GA, Yuo HS, Fries PD. Radiotherapy for nasolacrimal tract epithelial cancer. Int J Radiat Oncol. 1994;29(1):177‐181. https://doi.org/10.1016/0360-3016(94)90241-0.
Parmar DN, Rose GE. Management of lacrimal sac tumours. Eye. 2003;17(5):599‐606. https://doi.org/10.1038/sj.eye.6700516.
Ferrari D, Ghi MG, Franzese C, Codecà C, Gau M, Fayette J. The slippery role of induction chemotherapy in head and neck cancer: myth and reality. Front Oncol. 2020;10:7. https://doi.org/10.3389/fonc.2020.00007.
Vishak S, Rangarajan B, Kekatpure VD. Neoadjuvant chemotherapy in oral cancers: selecting the right patients. Indian J Med Paediatr Oncol. 2015;36(3):148‐153. https://doi.org/10.4103/0971-5851.166716.
Alam MS, Mukherjee B, Krishnakumar S. Clinical profile and management outcomes of lacrimal drainage system malignancies. Orbit. 2022;41(4):429‐436. https://doi.org/10.1080/01676830.2021.1925932.
Altan‐Yaycioglu R, Bolat F, Akova YA. Basosquamous carcinoma of the lacrimal sac: a case report. Orbit. 2007;26(4):267‐269. https://doi.org/10.1080/01676830600987565.
El Bousaadani A, Abada R, Belhadji M, Mahtar M. Primary epidermoid carcinoma of the lacrimal sac. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(5):373‐374. https://doi.org/10.1016/j.anorl.2015.03.013.
Bonder D, Fischer MJ, Levine MR. Squamous cell carcinoma of the lacrimal sac. Ophthalmology. 1983;90(9):1133‐1135. https://doi.org/10.1016/S0161-6420(83)80058-X.
Confalonieri F, Balia L, Piscopo R, Malvezzi L, Di Maria A. Epiphora and unrecognized paranasal sinuses pathology. Am J Ophthalmol Case Rep. 2020;19:100798. https://doi.org/10.1016/j.ajoc.2020.100798.
Curragh DS, Psaltis AJ, Tan NC, Selva D. Prelacrimal approach for nasolacrimal duct excision in the management of lacrimal system tumours. Orbit. 2019;38(4):308‐312. https://doi.org/10.1080/01676830.2018.1518464.
Curragh DS, James C, Selva D. Swinging inferior turbinate approach to the nasolacrimal duct. Orbit. 2020;39(2):112‐117. https://doi.org/10.1080/01676830.2019.1595007.
Griffith BH. Squamous cell carcinoma of the lacrimal sac. Plast Reconstr Surg. 1967;40(4):332‐336.
Jones IS. Tumors of the lacrimal sac. Am J Ophthalmol. 1956;42(4):561‐566. https://doi.org/10.1016/0002-9394(56)90781-4.
Kang B, Jung H, Shin J‐M, Park I‐H, Lee H‐M. Clinical characteristics of lacrimal sac tumors: report of ten cases. J Rhinol. 2017;24(1):14. https://doi.org/10.18787/jr.2017.24.1.14.
Katircioglu YA, Altiparmak UE, Akmansu H, Üstün H, Zorlu F, Duman S. Squamous cell carcinoma of the lacrimal sac. Orbit. 2003;22(3):151‐153. https://doi.org/10.1076/orbi.22.3.151.15616.
Knežević M, Stojković M, Jovanović M, Stanković Z, Rašić DM. A 7‐year prospective study of routine histopathological evaluation of the lacrimal sac wall incisional biopsy specimens obtained during external dacryocystorhinostomy in adults and a review of the literature. Med Oncol. 2012;29(1):396‐400. https://doi.org/10.1007/s12032-010-9810-y.
Levin PS, Dutton JJ. A 20‐year series of orbital exenteration. Am J Ophthalmol. 1991;112(5):496‐501. https://doi.org/10.1016/S0002-9394(14)76848-5.
Lu H, Yao M, Anderson K, Buatti J. Optically guided stereotactic radiotherapy for lacrimal sac tumors: a report on two cases. Technol Cancer Res Treat. 2008;7(1):35‐40. https://doi.org/10.1177/153303460800700104.
Mihailovic N, Steenken J, Elges S, et al. Masquerade lacrimal duct stenosis: prevalence of lacrimal sac tumors. Der Ophthalmol. 2020;117:439‐444.
Paxton BR, Davidorf FH, Makley TA. Carcinoma of lacrimal canaliculi and lacrimal sac. Arch Ophthalmol. 1970;84(6):749‐753. https://doi.org/10.1001/archopht.1970.00990040751010.
Rahangdale SR, Castillo M, Shockley W. MR in squamous cell carcinoma of the lacrimal sac. Am J Neuroradiol. 1995;16(6):1262‐1264. http://www.ncbi.nlm.nih.gov/pubmed/7677021.
Sakaida H, Kobayashi M, Yuta A, Imanishi Y, Majima Y. Squamous cell carcinoma of the nasolacrimal duct. Eur Arch Otorhinolaryngol. 2009;266(3):455‐458. https://doi.org/10.1007/s00405-008-0677-x.
Spaeth EB. Carcinomas in the region of the lacrimal sac. Arch Ophthalmol. 1957;57(5):689‐693. https://doi.org/10.1001/archopht.1957.00930050701009.
Spira R, Mondshine R. Demonstration of nasolacrimal duct carcinoma by computed tomography. Ophthalmic Plast Reconstr Surg. 1986;2(3):159‐162.
Stefanyszyn MA, Hidayat AA, Pe'er JJ, Flanagan JC. Lacrimal sac tumors. Ophthalmic Plast Reconstr Surg. 1994;10:184‐341.
Stephenson JA, Mayland DM, Ingall G, Frank TW. Squamous cell carcinoma of the lacrimal sac. Otolaryngol Neck Surg. 1988;99(5):524‐527.
Valenzuela AA, Selva D, McNab AA, Simon GB, Sullivan TJ. En bloc excision in malignant tumors of the lacrimal drainage apparatus. Ophthalmic Plast Reconstr Surg. 2006;22(5):356‐360. https://doi.org/10.1097/01.iop.0000235819.06507.b1.
Dharap Wagh R, Machakuri K, Ali MJ. Peripunctal squamous cell carcinoma with canalicular infiltration. Orbit. 2022;13:1‐3. https://doi.org/10.1080/01676830.2022.2085308.
Yoshida T, Nagata K, Mihashi S. Squamous cell carcinoma presumebly orignating from the lacrimal sac. Kurume Med J. 1982;29(Suppl):S57‐S59. https://doi.org/10.2739/kurumemedj.29.SUPPLEMENT_S57.
Brown OA. Tumor of the lacrimal sac. Am J Ophthalmol. 1960;49(6):1420. https://doi.org/10.1016/0002-9394(60)91370-2.
El‐Sawy T, Ali R, Nasser QJ, Esmaeli B. Outcomes of dacryocystorhinostomy in patients with head and neck cancer treated with high‐dose radiation therapy. Ophthalmic Plast Reconstr Surg. 2012;28(3):196‐198. https://doi.org/10.1097/IOP.0b013e31824c11df.
Golan S, Leibovitch I, Landsberg R. Unexpected pathologies in patients referred for endoscopic DCR. Eur Arch Otorhinolaryngol. 2014;271(11):3053‐3058. https://doi.org/10.1007/s00405-014-2892-y.
Heindl LM, Treutlein E, Jünemann AGM, Kruse FE, Holbach LM. Selektive Tränensackbiopsie bei externer Dakryozystorhinostomie. Der Ophthalmol. 2010;107(12):1139‐1144. https://doi.org/10.1007/s00347-010-2200-1.
Kadir SMU, Rashid R, Sultana S, et al. Lacrimal sac tumors: a case series. Ocul Oncol Pathol. 2022;8(1):42‐51. https://doi.org/10.1159/000520086.
Kumar VA, Esmaeli B, Ahmed S, Gogia B, Debnam JM, Ginsberg LE. Imaging features of malignant lacrimal sac and nasolacrimal duct tumors. Am J Neuroradiol. 2016;37(11):2134‐2137. https://doi.org/10.3174/ajnr.A4882.
Malick H, Kumari R, Lokovitis V, Mudhar H‐S, Vaidhyanath R, Sampath R. Squamous carcinoma ex pleomorphic adenoma of the lacrimal gland. Orbit. 2022;41(2):260‐263. https://doi.org/10.1080/01676830.2020.1841807.
Marthin JK, Lindegaard J, Prause JU, Heegaard S. Lesions of the lacrimal drainage system: a clinicopathological study of 643 biopsy specimens of the lacrimal drainage system in Denmark 1910‐1999. Acta Ophthalmol Scand. 2005;83(1):94‐99. https://doi.org/10.1111/j.1600-0420.2005.00383.x.
Matos AMF, Brega DR, Cunha LP, Gollner AM, Gonçalves ACP. Chronic unilateral tearing as a sign of lacrimal sac squamous cell carcinoma. Arq Bras Oftalmol. 2021;84(6):602‐605. https://doi.org/10.5935/0004-2749.20210099.
Meel R, Surve A, Bakhski S, Kashyap S, Gupta B, Sharma S. A rare case of pediatric lacrimal sac: squamous cell carcinoma. J Pediatr Ophthalmol Strabismus. 2019;56(6):e8‐e11. https://doi.org/10.3928/01913913-20181016-01.
Schubert W, Gear AJL, Lee C, et al. Incorporation of titanium mesh in orbital and midface reconstruction. Plast Reconstr Surg. 2002;110(4):1022‐1030. https://doi.org/10.1097/01.PRS.0000021307.23118.E7.
Sjö NC, von Buchwald C, Cassonnet P, et al. Human papillomavirus: cause of epithelial lacrimal sac neoplasia? Acta Ophthalmol Scand. 2007;85(5):551‐556. https://doi.org/10.1111/j.1600-0420.2007.00893.x.
Skinner HD, Garden AS, Rosenthal DI, et al. Outcomes of malignant tumors of the lacrimal apparatus. Cancer. 2011;117(12):2801‐2810. https://doi.org/10.1002/cncr.25813.